Epizyme (EPZM) Reaches $15.30 After 5.00% Down Move, Healthcare Services Group (HCSG) Sentiment Is 1.1

Healthcare Services Group, Inc. provides management, administrative and operating services to the housekeeping, laundry, linen, facility maintenance and dietary service departments of the healthcare industry, including nursing homes, retirement complexes, rehabilitation centers and hospitals located throughout the United States. The company has market cap of $3.35 billion. The Firm operates through two divisions: housekeeping, laundry, linen and other services , and dietary department services (Dietary). It has a 41.45 P/E ratio. The Company’s housekeeping service involves the management of a client’s housekeeping department, which is responsible for the cleaning, disinfecting and sanitizing resident rooms and common areas of a client’s facility.

The stock of Epizyme Inc (NASDAQ:EPZM) is a huge mover today! About 167,433 shares traded. Epizyme Inc (NASDAQ:EPZM) has risen 71.58% since September 29, 2016 and is uptrending. It has outperformed by 60.04% the S&P500.The move comes after 6 months negative chart setup for the $874.11M company. It was reported on May, 8 by Barchart.com. We have $14.54 PT which if reached, will make NASDAQ:EPZM worth $43.71 million less.

Investors sentiment is 1.09 in 2016 Q4. Its the same as in 2016Q3. It has no change, as 9 investors sold Epizyme Inc shares while 25 reduced holdings. only 8 funds opened positions while 29 raised stakes. 47.05 million shares or 4.32% more from 45.11 million shares in 2016Q3 were reported. Palo Alto Limited Liability Company reported 3.04M shares. Nationwide Fund Advisors has 0% invested in Epizyme Inc (NASDAQ:EPZM) for 44,878 shares. Meeder Asset Mngmt Inc has 32 shares. Nea Management Ltd holds 3.01% or 6.26M shares. Principal Financial Group has 0% invested in Epizyme Inc (NASDAQ:EPZM) for 93,658 shares. Price T Rowe Incorporated Md owns 15,800 shares. Vanguard Group reported 3.08M shares stake. Blackrock Inc owns 4,555 shares for 0% of their portfolio. Deerfield stated it has 0.8% in Epizyme Inc (NASDAQ:EPZM). Morgan Stanley accumulated 126,871 shares or 0% of the stock. Bankshares Of New York Mellon Corporation invested in 181,859 shares. Legal And General Gp Pcl has invested 0% in Epizyme Inc (NASDAQ:EPZM). Cormorant Asset Management Ltd Liability Corporation holds 0.26% or 159,513 shares in its portfolio. Cqs Cayman Ltd Partnership, Cayman Islands-based fund reported 634,300 shares. Moreover, State Board Of Administration Of Florida Retirement Sys has 0% invested in Epizyme Inc (NASDAQ:EPZM) for 15,347 shares.

Epizyme, Inc. is a clinical-stage biopharmaceutical company. The company has market cap of $874.11 million. The Firm discovers, develops and plans to commercialize epigenetic therapies for cancer patients. It currently has negative earnings. The Firm is engaged in the discovery and development of novel epigenetic therapies for cancer patients.

Among 8 analysts covering Epizyme (NASDAQ:EPZM), 8 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Epizyme had 10 analyst reports since August 6, 2015 according to SRatingsIntel. The stock of Epizyme Inc (NASDAQ:EPZM) earned “Buy” rating by Mizuho on Tuesday, May 10. The firm has “Buy” rating by Mizuho given on Thursday, August 6. The firm has “Buy” rating by Citigroup given on Tuesday, April 5. H.C. Wainwright upgraded Epizyme Inc (NASDAQ:EPZM) on Monday, March 14 to “Buy” rating. The firm earned “Outperform” rating on Monday, September 28 by RBC Capital Markets. Zacks downgraded the stock to “Buy” rating in Tuesday, August 25 report. The rating was maintained by JMP Securities on Wednesday, March 9 with “Market Outperform”.

Since November 9, 2016, it had 0 insider purchases, and 6 selling transactions for $228,957 activity. Another trade for 200 shares valued at $2,179 was made by Ho Peter Tai-Ching on Thursday, December 8. Another trade for 2,013 shares valued at $34,394 was made by Singer Andrew E. on Friday, March 31. Copeland Robert A also sold $87,213 worth of Epizyme Inc (NASDAQ:EPZM) shares.

Ratings analysis reveals 100% of Healthcare Services’s analysts are positive. Out of 2 Wall Street analysts rating Healthcare Services, 2 give it “Buy”, 0 “Sell” rating, while 0 recommend “Hold”. The lowest target is $37 while the high is $46. The stock’s average target of $42.50 is -6.55% below today’s ($45.48) share price. HCSG was included in 3 notes of analysts from July 29, 2015. Robert W. Baird initiated Healthcare Services Group, Inc. (NASDAQ:HCSG) rating on Friday, September 16. Robert W. Baird has “Outperform” rating and $46 target. The stock of Healthcare Services Group, Inc. (NASDAQ:HCSG) earned “Buy” rating by Stifel Nicolaus on Wednesday, October 14.

Analysts await Healthcare Services Group, Inc. (NASDAQ:HCSG) to report earnings on July, 11. They expect $0.29 EPS, up 11.54% or $0.03 from last year’s $0.26 per share. HCSG’s profit will be $21.36 million for 39.21 P/E if the $0.29 EPS becomes a reality. After $0.30 actual EPS reported by Healthcare Services Group, Inc. for the previous quarter, Wall Street now forecasts -3.33% negative EPS growth.

About 49,231 shares traded. Healthcare Services Group, Inc. (NASDAQ:HCSG) has risen 16.85% since September 29, 2016 and is uptrending. It has outperformed by 5.31% the S&P500.